Control Bionics Limited (ASX:CBL)
Australia flag Australia · Delayed Price · Currency is AUD
0.0600
0.00 (0.00%)
Sep 17, 2026, 2:55 PM AEST

Control Bionics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
4.774.776.145.355.644.5
Revenue Growth
-21.45%-22.43%14.84%-5.17%25.33%10.11%
Gross Profit
2.362.363.633.93.712.51
Operating Income
-6.66-6.66-5.72-5.78-5.24-6.18
Net Income
-7.27-7.27-6.11-5.91-5.63-6.1
Earnings Per Share
-0.02-0.02-0.02-0.04-0.06-0.07
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23
North America (US)
4.374.375.684.964.89
Japan and other markets
0.080.080.130.060.01
Corporate
0.550.550.56-0.71-0.43
Australia
0.850.851.261.091.23
R&D
0.630.630.720.950.41
Elimination
-1.08-1.08-1.31--
Total
5.45.47.046.366.11

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
2.152.150.671.060.995.27
Total Debt
0.620.620.440.960.130.28
Net Cash (Debt)
1.541.540.240.10.864.99
Net Cash Growth
-45.50%547.34%144.73%-88.77%-82.69%-59.56%
Net Cash Per Share
0.000.000.000.000.010.06

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-5.75-5.75-4.27-4.91-4.54-6.89
Capital Expenditures
-0.01-0.01-0.3-0.4-0.42-0.15
Free Cash Flow
-5.76-5.76-4.57-5.31-4.96-7.03
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
49.41%49.41%59.05%72.82%65.78%55.68%
Operating Margin
-139.79%-139.79%-93.16%-108.02%-92.78%-137.19%
Pretax Margin
-152.42%-152.42%-99.41%-110.52%-99.80%-135.53%
Profit Margin
-152.42%-152.42%-99.41%-110.52%-99.80%-135.53%
FCF Margin
-120.81%-120.81%-74.40%-99.24%-87.84%-156.26%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
6.846.401.441.941.404.34